Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

CME/CPD

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Hepatology

Original research

Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections

Online download statistics by month:

Online download statistics by month: August 2022 to August 2024

	Abstract	Full	Pdf
Aug 2022	3120	249	116
Sep 2022	1284	1082	146
Oct 2022	665	660	121
Nov 2022	317	308	106
Dec 2022	199	191	28
Jan 2023	187	184	38
Feb 2023	172	168	45
Mar 2023	161	154	35
Apr 2023	113	111	30
May 2023	521	490	120
Jun 2023	251	247	67
Jul 2023	90	86	47
Aug 2023	869	862	34
Sep 2023	1034	1037	42
Oct 2023	1245	1234	52
Nov 2023	1080	1076	19
Dec 2023	886	847	37
Jan 2024	810	806	29
Feb 2024	687	679	31
Mar 2024	758	757	64
Apr 2024	848	838	79
May 2024	863	857	34
Jun 2024	447	445	26
Jul 2024	224	222	36
Aug 2024	243	238	25
Total	17074	13828	1407